TransEnterix, Inc. to Present at the 28th Annual Piper Jaffray Healthcare Conference
TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P.
Slattery, Executive Vice President and Chief Financial Officer, will present at the 28th Annual Piper Jaffray Healthcare Conference
at the Lotte New York Palace Hotel in New York. The presentation is scheduled to take place at 10:50 am Eastern Time on Tuesday,
November 29, 2016.
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by
addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The company is focused on
the commercialization of the Senhance™ Surgical Robotic System, a multi-port robotic system that brings the advantages
of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera
control. The company is also developing the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical
platform. The Senhance Surgical Robotic System has been granted a CE Mark but is not currently available for sale in the United
States. For more information, visit the TransEnterix website at www.transenterix.com.
For TransEnterix, Inc.
Investor Contact:
Mark Klausner, +1-443-213-0501
invest@transenterix.com
or
Media Contact:
(For EU) Conrad Harrington, +44 (0)20 3178 8914
(For US) Hannah Dunning, +1-415-618-8750
TransEnterix-SVC@sardverb.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20161115005907/en/